Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
I-Mab ADR
(NQ:
IMAB
)
1.800
-0.010 (-0.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
88,595
Open
1.810
Bid (Size)
1.790 (20)
Ask (Size)
1.810 (26)
Prev. Close
1.810
Today's Range
1.800 - 1.830
52wk Range
1.170 - 3.255
Shares Outstanding
190,879,919
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
March 18, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million
February 11, 2024
I-Mab will become a completely US-based company, divesting itself of I-Mab Biopharma (Hangzhou), an unconsolidated affiliate. I-Mab Hangzhou will acquire rights to I-Mab’s drug assets in Greater China...
Via
Talk Markets
Performance
YTD
-20.00%
-20.00%
1 Month
-3.23%
-3.23%
3 Month
-9.09%
-9.09%
6 Month
+39.53%
+39.53%
1 Year
-41.56%
-41.56%
More News
Read More
Looking Into I-MAB's Recent Short Interest
February 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 15, 2023
Via
Benzinga
Week In Review: Two China Biopharmas Announce Billion Dollar Deals
October 14, 2023
Via
Talk Markets
Expert Ratings for I-MAB
September 25, 2023
Via
Benzinga
Where I-MAB Stands With Analysts
September 05, 2023
Via
Benzinga
Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq
September 30, 2023
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 28, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
September 28, 2023
Via
InvestorPlace
Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal
September 02, 2023
Via
Talk Markets
Analyst Ratings for I-MAB
August 18, 2023
Via
Benzinga
5 Analysts Have This to Say About I-MAB
June 05, 2023
Via
Benzinga
I-Mab Reveals Promising Results in Phase 1b/2 Study for Advanced Non-Small Cell Lung Cancer Treatment
May 26, 2023
Via
Benzinga
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
August 25, 2023
Via
InvestorPlace
Why Is TRACON Pharma (TCON) Stock Down 51% Today?
April 25, 2023
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 25, 2023
Via
InvestorPlace
Last Day Of Q1
March 31, 2023
Via
Benzinga
ImmuneOnco Banks On Cutting-edge Cancer Drugs To Attract IPO Cash
March 31, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
March 27, 2023
Via
Benzinga
Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 06, 2023
Via
Benzinga
Energizer, Children's Place And Other Big Stocks Moving Lower On Monday
February 06, 2023
Via
Benzinga
Dada Nexus, Bilibili And Other Big Stocks Moving Lower On Monday
January 30, 2023
Via
Benzinga
National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday
January 13, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.